Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_60da379fb33c192ef77f86a60c5ac029 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-252 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-179 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-24 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-39 |
filingDate |
2019-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df53e679013a376403152264a65904d7 |
publicationDate |
2021-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2021169977-A1 |
titleOfInvention |
Compositions of Transforming Growth Factor-Beta Type III Receptor and Uses for Ossification |
abstract |
This disclosure relates to compositions containing transforming growth factor-beta type III receptor (TβRIII) for ossification and methods related thereto. In certain embodiments, this disclosure relates to methods of using these compositions to improve bone formation after surgery to repair a bone void such as an orofacial cleft, cleft palate, or cleft lip. In a typical embodiment, the bone graft composition comprises exogenously added transforming growth factor-beta type III receptor (TβRIII) or variants and/or TβRII expressing cells. In certain embodiments, the graft composition is a biodegradable hydrogel based polymer impregnated with TβRIII or variants and/or TβRIII expressing cells. |
priorityDate |
2018-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |